Cover Image
市場調查報告書

全球多重診斷市場未來趨勢

Global Multiplexed Diagnostics Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 315306
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
Back to Top
全球多重診斷市場未來趨勢 Global Multiplexed Diagnostics Market 2014-2018
出版日期: 2014年10月01日 內容資訊: 英文 93 Pages
簡介

所謂多重診斷,是指1個週期的化驗次序之間分析複數檢體的檢驗設備。透過多重診斷,實施對一個標本的複數診斷、實驗。在開發這個之前,1次的化驗次序只檢驗一個檢體。多重診斷主要用於研究室和診斷檢驗室。特別在研究室,在醫藥品的藥物研發過程,多重診斷使用於檢查複數的檢體。多重診斷還用於藥物濫用檢測和藥物遺傳學實驗,傳染病檢查等,各種用途。全球多重診斷市場2013∼2018年的年複合成長率(CAGR)預計達到20.05%。

本報告提供全球的多重診斷市場相關分析、市場概要和結構、市場規模趨勢(今後5年的預測值)、各用途、技術、地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要
  • 主要的產品

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第7章 各用途的市場分析

  • 全球多重診斷市場:各用途的詳細分析

第8章 各技術的市場分析

  • 中密度多重化驗市場
  • 低密度多重化驗市場
  • 高密度多重化驗市場
  • 超高密度多重化驗市場
  • 下一代型定序市場

第9章 各地區分析

  • 南北美洲市場
  • 歐洲、中東、非洲(EMEA)地區市場
  • 亞太地區市場

第10章 購買標準

第11章 促進市場成長的要素

第12章 推動因素與其影響力

第13章 市場課題

第14章 推動因素、課題的影響力

第15章 市場趨勢

第16章 市場趨勢與其影響

第17章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
    • 企業合併、收購(M&A)
  • 市場佔有率分析
  • 其他著名的供應商
  • Affymetrix
    • 主要資料
    • 產業概要
    • 產業分類
    • 各部門的銷售額
    • 各地區的銷售額
    • 產業策略
    • 主要資訊
    • SWOT分析
  • Agilent Technologies
  • bioMeriux
  • Illumina
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific

第18章 其他相關分析

圖表一覽

目錄
Product Code: IRTNTR4240

About Multiplexed Diagnostics

Multiplexed diagnostics refer to equipment that are used for analyzing multiple analytes in the single cycle of the assay procedure. Multiplexed diagnostics can diagnose and run multiple tests on a specimen. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure. Multiplexed diagnostics find their use in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are used in various fields such as drugs-abuse screening, pharmacogenetics, and infection testing.

TechNavio's analysts forecast the Global Multiplexed Diagnostics market to grow at a CAGR of 20.05 percent over the period 2013-2018.

Covered in this Report

The Global Multiplexed Diagnostics market can be segmented into revenue generated from various multiplexed diagnostics technologies such as: Medium Density Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing.

TechNavio's report, Global Multiplexed Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Multiplexed Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Affymetrix
  • Agilent Technologies
  • Biomeurix
  • F. Hoffmann-La Roche
  • Illumina
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Abbott Laboratories
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Cepheid
  • Hologic
  • Luminex
  • Qaigen
  • Siemens Healthcare
  • ZOLL Medical

Market Driver

  • Technological Development

For a full, detailed list, view our report

Market Challenge

  • Accurate Diagnostics Testing

For a full, detailed list, view our report

Market Trend

  • Expanding Economies in the APAC Region

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global Multiplexed Diagnostics Market by Application

08. Market Segmentation by Technology

  • 08.1. Global Medium Density Multiplexed Assays Market
    • 08.1.1. Market Size and Forecast
  • 08.2. Global Low Density Multiplexed Assays Market
    • 08.2.1. Market Size and Forecast
  • 08.3. Global High Density Multiplexed Assays Market
    • 08.3.1. Market Size and Forecast
  • 08.4. Global Very High Density Multiplexed Assays Market
    • 08.4.1. Market Size and Forecast
  • 08.5. Global Next- Generation Sequencing Market
    • 08.5.1. Market Size and Forecast

09. Geographical Segmentation

  • 09.1. Multiplexed Diagnostics Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Multiplexed Diagnostics Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. Multiplexed Diagnostics Market in the APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors
  • 17.4. Affymetrix
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation
    • 17.4.4. Business Segmentation by Revenue 2013
    • 17.4.5. Business Segmentation by Revenue 2012 and 2013
    • 17.4.6. Sales by Geography
    • 17.4.7. Business Strategy
    • 17.4.8. Key Information
    • 17.4.9. SWOT Analysis
  • 17.5. Agilent Technologies
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation by Revenue 2013
    • 17.5.4. Business Segmentation by Revenue 2012 and 2013
    • 17.5.5. Geographical Segmentation by Revenue 2013
    • 17.5.6. Business Strategy
    • 17.5.7. Recent Developments
    • 17.5.8. SWOT Analysis
  • 17.6. bioMeriux
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation by Revenue 2013
    • 17.6.4. Geographical Segmentation by Revenue 2013
    • 17.6.5. Business Strategy
    • 17.6.6. Recent Developments
    • 17.6.7. SWOT Analysis
  • 17.7. Illumina
    • 17.7.1. Key Facts
    • 17.7.2. Business Overview
    • 17.7.3. Business Segmentation
    • 17.7.4. Sales Segmentation
    • 17.7.5. Business Strategy
    • 17.7.6. Key Information
    • 17.7.7. SWOT Analysis
  • 17.8. F. Hoffmann-La Roche
    • 17.8.1. Key Facts
    • 17.8.2. Business Overview
    • 17.8.3. Business Segmentation
    • 17.8.4. Sales Segmentation
    • 17.8.5. Business Strategy
    • 17.8.6. Key Information
    • 17.8.7. SWOT Analysis
  • 17.9. Thermo Fisher Scientific
    • 17.9.1. Key Facts
    • 17.9.2. Business Overview
    • 17.9.3. Business Segmentation
    • 17.9.4. Product Segmentation by Revenue
    • 17.9.5. Sales Segmentation
    • 17.9.6. Business Strategy
    • 17.9.7. Key Information
    • 17.9.8. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Multiplexed Diagnostics Market 2013-2018 (US$ million)
  • Exhibit 3: Medium Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 4: Low Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 5: High Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 6: Very High Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 7: Global Multiplexed Diagnostics Market Segmentation by Technology 2013
  • Exhibit 8: Global Medium Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 9: Global Low Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 10: Global High Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 11: Global Very High Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 12: Global Next- Generation Sequencing Market 2013-2018 (US$ million)
  • Exhibit 13: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018
  • Exhibit 14: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018 (US$ million)
  • Exhibit 15: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013
  • Exhibit 16: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018
  • Exhibit 17: Multiplexed Diagnostics Market in the Americas 2013-2018 (US$ million)
  • Exhibit 18: Multiplexed Diagnostics Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 19: Multiplexed Diagnostics Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 20: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018 (US$ million)
  • Exhibit 21: Affymetrix: Business Segmentation 2013
  • Exhibit 22: Affymetrix: Business Segmentation by Revenue 2013
  • Exhibit 23: Affymetrix: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 24: Affymetrix: Sales by Geography 2013
  • Exhibit 25: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 26: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 27: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 28: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 29: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 30: Illumina: Business Segmentation 2013
  • Exhibit 31: Illumina: Sales by Geography 2013
  • Exhibit 32: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 33: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013 and 2012
  • Exhibit 34: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
  • Exhibit 35: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
  • Exhibit 36: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
  • Exhibit 37: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
  • Exhibit 38: Thermo Fisher Scientific: Sales by Geography 2013
Back to Top